ConductScience.org, home

Paper39095877

Prevalence and characteristics of patients with incidental cardiac uptake on bone scintigraphy.

Son J and 2 others. J Cardiovasc Imaging, 2024. Cited by 3 papers, by iCite.

Cite this record

ConductScience Library. Prevalence and characteristics of patients with incidental cardiac uptake on bone scintigraphy. Papers, record 39095877. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39095877

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Prevalence and characteristics of patients with incidental cardiac uptake on bone scintigraphy.
PubMed
Journal
J Cardiovasc Imaging
PubMed
Year
2024
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
3
iCite
Relative citation ratio, by iCite
0.6, provisional
iCite
Revised in PubMed
2024-08-06
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References16

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
127143678Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis.Circulation2016https://conductscience.org/library/papers/27143678PubMed
2104017Bone scintigraphy in renal osteodystrophy.J Nucl Med1978https://conductscience.org/library/papers/104017PubMed
331480867Expert Consensus Recommendations for the Suspicion and Diagnosis of Transthyretin Cardiac Amyloidosis.Circ Heart Fail2019https://conductscience.org/library/papers/31480867PubMed
435361352Critical Comparison of Documents From Scientific Societies on Cardiac Amyloidosis: JACC State-of-the-Art Review.J Am Coll Cardiol2022https://conductscience.org/library/papers/35361352PubMed
531019172Prevalence of Positive 99 mTc-DPD Scintigraphy as an Indicator of the Prevalence of Wild-type Transthyretin Amyloidosis in the Elderly.Int Heart J2019https://conductscience.org/library/papers/31019172PubMed
631553132Transthyretin cardiac amyloidosis: an update on diagnosis and treatment.ESC Heart Fail2019https://conductscience.org/library/papers/31553132PubMed
724831216Identification of TTR-related subclinical amyloidosis with 99mTc-DPD scintigraphy.JACC Cardiovasc Imaging2014https://conductscience.org/library/papers/24831216PubMed
836710122Nuclear medicine imaging findings in end-stage renal disease and renal transplant complications.Clin Radiol2023https://conductscience.org/library/papers/36710122PubMed
933728572The prevalence of TTR cardiac amyloidosis among patients undergoing bone scintigraphy.J Nucl Cardiol2021https://conductscience.org/library/papers/33728572PubMed
1032476490Cardiac Amyloidosis: Evolving Diagnosis and Management: A Scientific Statement From the American Heart Association.Circulation2020https://conductscience.org/library/papers/32476490PubMed
1136799266The short and long-term characteristics and outcomes of patients with grade 1 myocardial uptake on cardiac scintigraphy.ESC Heart Fail2023https://conductscience.org/library/papers/36799266PubMed
1216168294Noninvasive etiologic diagnosis of cardiac amyloidosis using 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy.J Am Coll Cardiol2005https://conductscience.org/library/papers/16168294PubMed
1333826207Diagnosis and treatment of cardiac amyloidosis. A position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases.Eur J Heart Fail2021https://conductscience.org/library/papers/33826207PubMed
1429903517Prevalence of wild type ATTR assessed as myocardial uptake in bone scan in the elderly population.Int J Cardiol2018https://conductscience.org/library/papers/29903517PubMed
1531109193Natural History, Quality of Life, and Outcome in Cardiac Transthyretin Amyloidosis.Circulation2019https://conductscience.org/library/papers/31109193PubMed
1632266575Diagnosis of Transthyretin Amyloid Cardiomyopathy.Cardiol Ther2020https://conductscience.org/library/papers/32266575PubMed

Download CSV of references

Cited by3

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.

PMIDTitleJournalYearIn PapersSource
42325163Prevalence of cardiac amyloidosis in screening studies: a systematic review and meta-analysis.ESC Heart Fail2026https://conductscience.org/library/papers/42325163PubMed
41590238Incidental Cardiac Uptake on 99mTc-HMDP Bone Scintigraphy in Oncology Patients: Two Cases of Transthyretin Amyloid Cardiomyopathy with Literature Review.Diseases2026https://conductscience.org/library/papers/41590238PubMed
39343981To see those not to be seen: cardiac uptake on noncardiac imaging.J Cardiovasc Imaging2024https://conductscience.org/library/papers/39343981PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39095877

GET https://conductscience.org/api/papers/v1/39095877/authors